Since 1923, we have been focused on innovation and leadership in diabetes care. Today we have a broad portfolio of medicines.
Since the launch of our first pen needle in 1985, we have been committed to enhancing injection experience by putting technology in patient hands.
Access information on our products for rare bleeding disorders, growth hormone-related disorders, and women's health.
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
The link above used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product.
Welcome to our U.S. social hub! Check out our community guidelines,
then find the account that matches your interest and connect to stay
up to date on our company and communities.
Novo Nordisk US
We share news and information about our company, and stories from
our patients, employees and community members.
Changing Hemophilia® is a community for people whose
lives are affected by hemophilia and rare bleeding disorders.
More than Height
More Than Height is a community intended to increase awareness that
growth can be an important sign of a child’s overall health and
Get Real About Diabetes
Managing diabetes isn’t complicated, but it takes commitment. Every.
Race With Insulin
INDYCAR driver partners with Novo Nordisk to raise awareness.
The Diabetes Download
Looking for answers to commonly asked diabetes questions—and some
that aren't so common. Hear from experts—from a professional chef to a
doctor, and many more.
Novo Nordisk on LinkedIn
Headquartered in Denmark, Novo Nordisk employs approximately 43,100
people in 79 countries and markets its products in more than 170 countries.